Skip to main content

Table 1 Frequencies of regions of gains, losses and amplifications in invasive micropapillary carcinomas and in oestrogen receptor–positive and grade-matched invasive ductal carcinomas of no special type a

From: Polarity gene alterations in pure invasive micropapillary carcinomas of the breast

SNP start

SNP end

Chr

Cytoband

IMPCs (%)

IDC-NSTs (%)

Genes of interest

Common regions

      

 Gains

      

  36948617

146292734

8

p11.23-q24.3

60

45

 

 Losses

      

  113565

35436036

8

p23.3-p12

63

63

 

  46534977

90163275

16

q11.2-q24.3

55b

54

 

  6689

18896297

17

p13.3-p11.2

46

43b

 

  16055171

51219006

22

q11.1-q13.33

52

40

 

Specific regions

      

 Gains

      

  197811282

249198692

1

q31.3-q44

23

48

 

  52579874

67308196

17

q22-q24.3

47

25

 

  33435161

62648208

20

q13.12-q13.33

17

44

 

 Losses

      

  101380020

125365648

6

q16.3-q22.31

45b

20

 

  705598

13611533

18

p11.32-p11.21

15

42

 

  28175177

35313501

18

q12.1-q12.2

24

40

 

 Amplifications

      

  37097563

38618768

8

p11.23-p11.22

13

26

FGFR1, PPAPDC1B, WHSC1L1

  94967717

97023919

8

q22.1

21

5

RAD54B, CCNE2, TP53INP1

  115849871

138121678

8

q23.3-q24.23

21

14

MYC

  69073647

70229171

11

q13.3-q25

7

22

CCND1, ORAOV1, FGF19, FGF4, FGF3

  37298761

38225021

17

q12-q21.1

22

24

STARD3, ERBB2, GRB7

  57159990

62354992

17

q22-q23.3

22

7

BCAS3, TBX2, TLK2, TANC2, PPM1D

  50695849

52586281

20

q13.2

15

26

ZNF217, BCAS1

  1. aChr, Chromosome; IDC-NST: invasive carcinoma of no special type; IMPC, Invasive micropapillary carcinoma; SNP, Single-nucleotide polymorphism. Recurrent gains, losses or amplifications observed in more than 20% of cases after exclusion of genomic variants according to the Database of Genomic Variants (http://dgv.tcag.ca/dgv/app/home). SNP start and SNP end refer to SNP positions corresponding to the boundaries of gains, losses or amplifications. Genomic positions are provided according to human genome 19 (hg19) references in base pairs. bExistence of a homozygous deletion is observed in one case among IMPCs and IDC-NSTs studied. The lower part of the table lists the specific regions of gains, losses and amplifications that were statistically different between IMPCs and IDC-NSTs with P < 0.05 by Fisher’s exact test.